P.A.W. Capital’s Celgene Corp CELG Stock Holding History

P.A.W. Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,000	Closed	-$446K	–	71
2018 Q1	$446K	Buy	+5,000	New	+$480K	0.54%	55
2017 Q4	–	Sell	-10,000	Closed	-$1.46M	–	77
2017 Q3	$1.46M	Sell	10,000 -2,000	-17%	-$272K	1.53%	21
2017 Q2	$1.56M	Sell	12,000 -2,000	-14%	-$245K	1.56%	30
2017 Q1	$1.74M	Hold	14,000	–	–	1.76%	14
2016 Q4	$1.62M	Buy	14,000 +9,000	+180%	+$1M	1.83%	22
2016 Q3	$523K	Buy	+5,000	New	+$541K	0.56%	62

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

P.A.W. Capital's CELG Position: Q2 2018 in Review

P.A.W. Capital sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 5,000 shares — an estimated $446K sold.

P.A.W. Capital first reported a position in CELG in Q3 2016 and held it in 6 quarters. The position peaked at $1.74M in Q1 2017. 1,359 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

P.A.W. Capital reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
P.A.W. Capital sold 5,000 Celgene Corp shares in Q2 2018, an estimated $446K.
P.A.W. Capital first reported a position in Celgene Corp in Q3 2016 and held it in 6 quarters.
P.A.W. Capital's Celgene Corp position peaked at $1.74M in Q1 2017.
1,359 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on P.A.W. Capital's 13F filing for Q2 2018, filed 25 Jul 2018.